phone icon  Int'l : +1-503-894-6022
Allied Market Research
0
Shopping Cart is Empty..
$ 0

Biomaterials are artificially derived natural materials that are used in medical applications such as organ transplantation and replacement of tissues. The global market for medical devices was accounted to $240 billion in 2013. This shows the potential for growth of biomaterial market. Increase in aging population is the major driver for biomaterial market. Due to the increase in number of aging patients, the usage of biomaterial in wound healing, plastic surgery, neurology and tissue engineering is increasing. According to the Society for Biomaterials, there are more than 5000 novel research article published every year for improved wound care techniques and surgical devices. Biomaterials market growth is hindered by certain factors such as inflammatory responses and strict government regulations for commercialization. In 1999, Government of Norway conducted “Dental Biomaterial- Adverse Reaction Unit” activity to control and evaluate adverse implication in dental fields.

The global biomaterial market is challenged by above restraints; however, companies are developing novel techniques to overcome these challenges. Companies are collaborating to build extra competitive advantage in biomaterial market. For Example, Wright Medical Group recently acquired BioMimetic Therapeutics Inc. to explore opportunities for Wright’s Extermities business. This report provides key strategies adopted by top players engaged in this business. The report provides regulatory intelligence for biomaterial according to geographies.

Key companies included in the report are Morgan Tecxhnical Ceramics, BASF SE, Collagen Matrix Inc., Wright Medical Group Inc., Bayer AG, Kyocera Corporation, Cam Bioceramics BV, Ticona Gmbh, Noble Biomaterials Inc., and Biomet Inc

KEY BENEFITS

  • Key developmental strategies adopted by top market players engaged in this business to provide better understanding of potential opportunities and challenges in this market
  • Market estimation of applications, types of materials and geographic segment is derived from current market scenario and expected market trends
  • The report provides an in-depth understanding of the market scenarios in various geographic regions so that key players can make plans to explore opportunities in specific regions
  • In depth analysis of key drivers, restraints and opportunities of biomaterials market with impact analysis
  • Value chain analysis, Porter’s five forces model, top investment pockets (GE9 Cell Matrix) are analyzed and presented in detail in the report

KEY MARKET SEGMENTSBY TYPE OF MATERIAL

  • Metals
  • Polymers
  • Ceramics
  • Natural Biomaterial

BY APPLICATION

  • Cardiovascular
  • Dental
  • Orthopedic
  • Wound Healing
  • Plastic Surgery
  • Ophthalmology
  • Tissue Engineering
  • Neurological Disorders
  • Others

BY GEOGRAPHY

  • North America
  • EMEA
  • Asia Pacific
  • ROW

KEY AUDIENCES

  • Medical device manufacturing companies
  • Pharmaceutical Companies
  • Research Institutes
  • Academic Institutes
Let us know more about your research need and we will customize an offer exclusively for you!
*
*
*
*
*
*
*
security
*

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
SINGLE USER
GROUP LICENSE
SITE LICENSE
GLOBAL LICENSE
$3792
$4440
$6060
$8724
LICENSE INFO
Users/Sharing
Restricted to one authorized user

Limited to 5 authorized users

Up to 25 users


unlimited within company / enterprise
Copy/Paste
Allowed up to 20% of the content
Allowed up to 25% of the content
Allowed up to 50% of the content
allowed 100%

Printing
One print only

Five Prints

Unlimited for internal use
Unlimited for internal use
Delivery Formats
ADDED BENIFITS
20% Free customization (Pre-sale)
16 Analyst hour support (Post Sale)
40 Analyst hour support (Post Sale)
160 hours of mini-consult
Free quarterly industry update
Free report on update (within 180 days)
MULTIPLE PURCHASE
Complimentary report with 2 reports
Complimentary report with 3 reports
Subscription Model
Have questions ?
connect
Need to add more ?
request

Single User $4740
$3792
Group User $5550
$4440
Site User $7575
$6060
Global User $10905
$8724
buy now

Discount will be applied in cart.
First time buyer ?
Check offers and discount
on this report
REQUEST QUOTE
Need More Information
phone_n +1-503-894-6022

Help AMR help@alliedmarketresearch.com
Or
Send Enquiry
WHY ALLIED MARKET RESEARCH?
Infallible Methodology
To ensure high level data integrity, accurate analysis and impeccable forecasts
ANALYST SUPPORT
For complete satisfaction
CUSTOMIZATION
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET
Targeted market view to eliminate redundant information to provide valued information and save time of the reader
RECENTLY VIEWED REPORTS
get_n
SIMILAR MARKET REPORTS
  • ...
    Bioinformatics is defined as conceptualize biology in terms of molecules and then the application of information technology to organize and understand the data which is associated with these molecules on large scale bases. Bioinformatics utilizes computer to collect data, analyze, integrate and store the molecular ad biological data, which is then utilized in application such as drug development and discovery.
    May 2014 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Intravenous Immunoglobulin (IVIG) is a sterile solution of antibodies collected from healthy donors, which is administered through the veins into the body. Currently, the immunoglobulin industry is growing on account of increasing FDA/EMA approvals and government support. IVIG usage against the conditions within the criteria (i.e. FDA/EMA approved indications) have increased greatly and the largest increase found in Chronic Inflammatory demyelinating polyneuropathy (CIDP), Hypogammaglobulinemia and immunodeficiency diseases.
    Apr 2015 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
  • ...
    Hydrogel is a water-insoluble polymer chain network that can retain high water content within its structure (about 90% water in the gel base). Hydrogels are used in hygiene products such as baby diapers, sanitary pads, adult incontinence pads, and soft contact lenses. In addition, they are increasingly used in wound care dressings for cleansing and debriding necrotic tissues in wounds. They are also used during the treatment of partial or thick wounds, necrotic wounds, burns, and autolytic debridement.
    May 2016 | Price: $4515(SU) €0(SU) £0(SU) | View Details >>
ON DEMAND REPORTS
  • ...
    Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in the cord blood bank market. Cord blood market is expected to grow at 33.5% CAGR from 2012-2020. Public cord blood banks share more revenue as compared to private cord blood banks. Increase in awareness for cord blood storage by the government and private organizations is supporting the growth of UCB stem cell storage market.
    Aug 2016 | View Details >>
  • ...
    Transdermal route is a promising alternative for oral and injectable drug delivery wherein skin is the primary site for drug administration. This drug delivery system offers certain benefits, such as non-invasiveness, controlled & complete drug delivery from the dosage form and improved patient compliance. Transdermal patches, ointments, gel and implants are the popular transdermal drug delivery systems. Over the past few years, transdermal patches have gained significant importance.
    Aug 2016 | View Details >>
  • ...
    The global market for pharmaceutical contract manufacturing represents one of the fastest growing markets and it is expected to proffer enormous opportunities in the near future. Contract manufacturing contributes significantly to the overall outsourcing market, owing to its popularity and widespread adoption by pharmaceutical companies. Cost containment issues resulted from global economic constraints, have exerted extensive pressure on pharmaceutical manufacturers to reduce the cost of products. Hence, to make way out of this situation, pharma companies are looking to reduce the manufacturing cost.
    Aug 2016 | View Details >>